Feliway can also reduce stress when travelling, visiting the vet or cattery, redecorating and moving home. Simply shake the bottle and apply the spray directly to the object or areas 15 minutes before you introduce your cat or kitten to the area. Do not spray directly onto your cat. When a cat feels safe in its environment, it will rub its head against furniture, walls or the bottom of the curtains, leaving behind substances called facial pheromones. Feliway is a synthetic copy of this pheromone and is proven to reassure and comfort cats, helping them to cope with changes in their environment. Developed after years of veterinary research, Feliway is scientifically proven to help stop unwanted behaviour in cats and has 18 scientific studies.
Pets at Home offers the ultimate pet shop experience. It really is a paradise for pets and pet owners. We have all the pet supplies, pet food, toys and accessories you and your pet need at great value prices. Alongside our great range of products for your pet, we also offer a wealth of advice and support. Explore the resources below to see what else we can offer you and your pet. We are unable to serve international traffic at this time. We apologize for any inconvenience.
Please call our toll free number to discuss ordering. Gentocin Topical Spray for Animal Use — Drugs. Learn about Gentocin Topical Spray for animal usage including: active ingredients, directions for use, precautions, and storage information. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Each mL contains: gentamicin sulfate, USP equivalent to 0. 57 mg gentamicin base, betamethasone valerate, USP equivalent to 0.
284 mg betamethasone, 163 mg isopropyl alcohol, propylene glycol, methylparaben and propylparaben as preservatives, purified water q. Hydrochloric acid may be added to adjust pH. Gentamicin sulfate veterinary is a mixture of sulfate salts of the antibiotics produced in this fermentation. The salts are weakly acidic and freely soluble in water. Gentamicin sulfate veterinary contains not less than 500 micrograms of gentamicin base per milligram. Betamethasone valerate is a synthetic glucocorticoid. Gentamicin, a broad-spectrum antibiotic, is a highly effective topical treatment for bacterial infections of the skin.
This human bioassay technique has been found reliable for evaluating the vasoconstrictor properties of new topical corticosteroids and is useful in predicting clinical efficacy. Betamethasone valerate in veterinary medicine has been shown to provide anti-inflammatory and antipruritic activity in the topical management of corticosteroid-responsive infected superficial lesions in dogs. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Additionally, corticosteroids administered to dogs, rabbits, and rodents during pregnancy have produced cleft palate. Other congenital anomalies including deformed forelegs, phocomelia, and anasarca have been reported in offspring of dogs that received corticosteroids during pregnancy. For the treatment of infected superficial lesions in dogs caused by bacteria susceptible to gentamicin. If hypersensitivity to any of the components occurs, discontinue treatment and institute appropriate therapy.
Prior to treatment, remove excessive hair and clean the lesion and adjacent area. Hold bottle upright 3 to 6 inches from the lesion and depress the sprayer head twice. Administer 2 to 4 times daily for 7 days. Each depression of the sprayer head delivers 0. 7 mL of GENTOCIN Topical Spray. GENTOCIN Topical Spray was well-tolerated in an abraded skin study in dogs.
No treatment-related toxicological changes in the skin were observed. Systemic effects directly related to treatment were confined to histological changes in the adrenals, liver, and kidney and to organ-to-body weight ratios of adrenals. All were dose related, were typical for or not unexpected with corticosteroid therapy, and were considered reversible with cessation of treatment. Side effects such as SAP and SGPT enzyme elevations, weight loss, anorexia, polydipsia, and polyuria have occurred following parenteral or systemic use of synthetic corticosteroids in dogs. Cushing’s syndrome in dogs has been reported in association with prolonged or repeated steroid therapy. Use of topical antibiotics may permit overgrowth of nonsusceptible bacteria, fungi, or yeasts. If this occurs, treatment should be instituted with other appropriate agents as indicated. Administration of recommended dose beyond 7 days may result in delayed wound healing. Animals treated longer than 7 days should be monitored closely. Oral or parenteral use of corticosteroids, depending on dose, duration, and specific steroid may result in inhibition of endogenous steroid production following drug withdrawal. In patients presently receiving or recently withdrawn from systemic corticosteroid treatments, therapy with a rapidly acting corticosteroid should be considered in especially stressful situations.